Publications | Lund University Publications

41 – 50 of 78

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221462-8902%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
4
5
6
7
8
next »

2012
Mark The hyperstimulated beta-cell: prelude to diabetes?
Boitard, Christian ; Accili, Domenico ; Ahrén, Bo ^LU ; Cerasi, Erol ; Seino, Susumu and Thorens, Bernard (2012) In Diabetes, Obesity and Metabolism 14(S3).
- Contribution to journal › Debate/Note/Editorial
Mark Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon, C F ; Mannucci, E and Ahrén, Bo ^LU (2012) In Diabetes, Obesity and Metabolism 14(8). p.762-767
- Contribution to journal › Article
Mark Using albumin to improve the therapeutic properties of diabetes treatments.
Ahrén, Bo ^LU and Burke, B (2012) In Diabetes, Obesity and Metabolism 14. p.121-129
- Contribution to journal › Article
2011
Mark Editorial: Long in the shade, glucagon re-occupies centre court
Henquin, J. -C. ; Accili, D. ; Ahrén, Bo ^LU ; Boitard, C. ; Seino, S. and Cerasi, E. (2011) In Diabetes, Obesity and Metabolism 13(Suppl. 1).
- Contribution to journal › Debate/Note/Editorial
Mark Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
Ahrén, Bo ^LU ; Schweizer, A. ; Dejager, S. ; Villhauer, E. B. ; Dunning, B. E. and Foley, J. E. (2011) In Diabetes, Obesity and Metabolism 13(9). p.775-783
- Contribution to journal › Scientific review
Mark Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.
Alam, M ; Van der Schueren, B J ; Ahrén, Bo ^LU ; Wang, G C ; Swerdlow, N J ; Arias, S ; Bose, M ; Gorroochurn, P ; Teixeira, J and McGinty, J , et al. (2011) In Diabetes, Obesity and Metabolism 13(4). p.378-381
- Contribution to journal › Article
Mark Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)
Lindblad, U. ; Lindberg, Gunnar ^LU ; Månsson, Nils-Ove ^LU ; Ranstam, Jonas ^LU ; Tyrberg, Maria ^LU ; Jansson, S. ; Lindwall, K. ; Svärdh, Mona ^LU ; Kindmalm, L. and Melander, Arne ^LU (2011) In Diabetes, Obesity and Metabolism 13(2). p.185-188
- Contribution to journal › Article
Mark Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.
Lindgren, Ola ^LU ; Carr, R ; Holst, J J ; Deacon, C and Ahrén, Bo ^LU (2011) In Diabetes, Obesity and Metabolism 13. p.863-865
- Contribution to journal › Article
Mark Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
Ahrén, Bo ^LU ; Foley, J E and Bosi, E (2011) In Diabetes, Obesity and Metabolism 13(3). p.193-203
- Contribution to journal › Article
Mark The future of incretin-based therapy: novel avenues-novel targets.
Ahrén, Bo ^LU (2011) In Diabetes, Obesity and Metabolism 13 Suppl 1. p.158-166
- Contribution to journal › Article

« previous
1
…
4
5
6
7
8
next »

your query:: Remove issn: 1462-8902